FR EA

Matter 1018-00005 — Penterra Pharmaceuticals Corp

2022 · 12 documents · Real Estate · D. Lindqvist

21.5hours logged
$5,500unbilled WIP
$11,700billed to date
DateLawyerDescription HoursAmount
2025-05-01 A. Nakamura Analyze dormancy confirmation letter 3.6 $2,880
2025-05-03 C. Fontaine Correspondence re email clarion3 results impact 0.5 $400
2025-05-15 M. Sage Legal research re email client hold dormancy notice 4.0 $3,200
2025-05-25 L. Marchetti Legal research re email patent counsel labeling coordination 2.7 $2,160
2025-05-25 J. Whitfield Analyze engagement letter penterra snda 4.3 $3,440
2025-06-15 P. Iyer Conference call re draft medication guide psoriasis rev2 3.1 $2,480
2025-06-12 L. Marchetti Legal research re draft uspi psoriasis rev3 0.6 $480
2025-06-12 C. Fontaine Legal research re file preservation dormancy memo 2.7 $2,160
2025-06-02 J. Whitfield Draft and revise pediatric deferral analysis memo 0 $0
2025-06-15 L. Marchetti Legal research re post clarion3 regulatory path memo 0 $0
2025-06-20 E. Alder Draft and revise regulatory strategy memo velonatib psoriasis 0 $0
2025-07-17 L. Marchetti Draft and revise rems assessment memo 0 $0
Invoice preview 21.5 $5,500